Medicamen Biotech Limited has entered into a long-term Manufacturing & Supply Agreement with a prominent pharmaceutical distributor and marketing entity operating in the United States and Europe. 

This strategic collaboration aims to enhance Medicamen Biotech’s global presence and leverage its manufacturing capabilities.

Under the agreement, Medicamen Biotech will manufacture products for the US-based entity according to its technical specifications.

The collaboration is expected to last for ten years, ensuring a stable and long-term engagement. 

The agreement is strictly a manufacturing and supply arrangement with no share exchange involved. Additionally, 25% of the agreement’s total consideration has been received upon signing.